1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow CX-2029: new trials by email Literature Review of CX-2029 trials Research Report on CX-2029
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PROCLAIM-CX-2029: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2029 for Patients With Solid Tumors or DLBCL CX-2029 - Solid Tumor, Adult, Head and Neck Cancer | Phase 1 / Phase 2 | Completed | CytomX Therapeutics | 133 | 2018-06-15 | 2024-01-23 |
Carcinoma, Non-Small-Cell Lung (1) · Esophageal Neoplasms (1) · Head and Neck Neoplasms (1) · Lymphoma, Large B-Cell, Diffuse (1) · Neoplasms (1)
South Korea (1) · Spain (1) · United Kingdom (1) · United States (1)